JCI - Citations to New and emerging HDAC inhibitors for cancer treatment

Citations to this article

New and emerging HDAC inhibitors for cancer treatment

Alison C. West, Ricky W. Johnstone

Alison C. West, Ricky W. Johnstone

Published January 2, 2014
Citation Information: J Clin Invest. 2014;124(1):30-39. https://doi.org/10.1172/JCI69738.

View: Text | PDF

Total citations by year

Year:	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2009	Total
Citations:	25	32	47	59	68	56	75	72	95	82	61	22	1	695

Citation information

Citations to this article in year 2022 (59)

Title and authors	Publication	Year
Interaction of Immune and Cancer Cells M Klink, I Szulc-Kielbik		2022
Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology M Pozo, G Meredith, E Entcheva	Cells	2022
How to Slow down the Ticking Clock: Age-Associated Epigenetic Alterations and Related Interventions to Extend Life Span A Galow, S Peleg	Cells	2022
The paradigm of drug resistance in cancer: an epigenetic perspective S Adhikari, A Bhattacharya, S Adhikary, V Singh, S Gadad, S Roy, C Das	Bioscience Reports	2022
Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies J Wilczyński, M Wilczyński, E Paradowska	International journal of molecular sciences	2022
HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer Y Zhou, X Jin, H Yu, G Qin, P Pan, J Zhao, T Chen, X Liang, Y Sun, B Wang, D Ren, S Zhu, H Wu	Theranostics	2022
Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [18F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain Clauß O, Schäker-Hübner L, Wenzel B, Toussaint M, Deuther-Conrad W, Gündel D, Teodoro R, Dukić-Stefanović S, Ludwig FA, Kopka K, Brust P, Hansen FK, Scheunemann M	Pharmaceuticals	2022
Molecular mechanisms of bifunctional vitamin D receptor agonist-histone deacetylase inhibitor hybrid molecules in triple-negative breast cancer Barbier C, Mansour A, Ismailova A, Sarmadi F, Scarlata DA, Bouttier M, Zeitouni C, Wang C, Gleason JL, White JH	Scientific Reports	2022
Deacetylation of YAP1 Promotes the Resistance to Chemo- and Targeted Therapy in FLT3-ITD+ AML Cells Feng P, Zhang J, Zhang J, Liu X, Pan L, Chen D, Ji M, Lu F, Li P, Li G, Sun T, Li J, Ye J, Ji C	Frontiers in Cell and Developmental Biology	2022
Anti-Colon Cancer Activity of Novel Peptides Isolated from In Vitro Digestion of Quinoa Protein in Caco-2 Cells Fan X, Guo H, Teng C, Zhang B, Blecker C, Ren G	Foods	2022
MS275 as Class I HDAC inhibitor displayed therapeutic potential on malignant ascites by iTRAQ-based quantitative proteomic analysis Du L, Wang D, Wei X, Liu C, Xiao Z, Qian W, Song Y, Hou X	BMC Gastroenterology	2022
Uveal Melanoma Cell Line Proliferation Is Inhibited by Ricolinostat, a Histone Deacetylase Inhibitor Sundaramurthi H, García-Mulero S, Tonelotto V, Slater K, Marcone S, Piulats JM, Watson RW, Tobin DJ, Jensen LD, Kennedy BN	Cancers	2022
HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma Gong W, Wang L, Schubert ML, Kleist C, Neuber B, Wang S, Yang M, Hückelhoven-Krauss A, Wu D, Schmitt A, Müller-Tidow C, Shiku H, Schmitt M, Sellner L	Biomedicines	2022
LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression Xu X, Ding P, Shi L, Wu G, Ma X	BMC Cancer	2022
Hormonal and Genetic Regulatory Events in Breast Cancer and Its Therapeutics: Importance of the Steroidogenic Acute Regulatory Protein Manna PR, Ahmed AU, Molehin D, Narasimhan M, Pruitt K, Reddy PH	Biomedicines	2022
Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma Xu Y, Liao W, Luo Q, Yang D, Pan M	Frontiers in immunology	2022
Upregulation of p75NTR by Histone Deacetylase Inhibitors Sensitizes Human Neuroblastoma Cells to Targeted Immunotoxin-Induced Apoptosis Dedoni S, Olianas A, Manconi B, Collu M, Tuveri B, Vincis ME, Olianas MC, Onali P	International journal of molecular sciences	2022
Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring Moi D, Citarella A, Bonanni D, Pinzi L, Passarella D, Silvani A, Giannini C, Rastelli G	RSC Advances	2022
Design, Synthesis, and Biological Evaluation of 2-Anilino-4-Triazolpyrimidine Derivatives as CDK4/HDACs Inhibitors Wang S, Han S, Cheng W, Miao R, Li S, Tian X, Kan Q	Drug design, development and therapy	2022
Insights into the therapeutic potential of histone deacetylase inhibitor/immunotherapy combination regimens in solid tumors. Sedky NK, Hamdan AA, Emad S, Allam AL, Ali M, Tolba MF	Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico	2022
Untargeted LC-MS/MS Metabolomics Study on the MCF-7 Cell Line in the Presence of Valproic Acid. Estrada-Pérez AR, Rosales-Hernández MC, García-Vázquez JB, Bakalara N, Fromager B, Correa-Basurto J	International journal of molecular sciences	2022
The Histone Deacetylase Inhibitor I1 Induces Differentiation of Acute Leukemia Cells With MLL Gene Rearrangements via Epigenetic Modification. Yao J, Li G, Cui Z, Chen P, Wang J, Hu Z, Zhang L, Wei L	Frontiers in pharmacology	2022
Classification models and SAR analysis on HDAC1 inhibitors using machine learning methods. Li R, Tian Y, Yang Z, Ji Y, Ding J, Yan A	Molecular Diversity	2022
Three-dimensional quantitative structural-activity relationship and molecular dynamics study of multivariate substituted 4-oxyquinazoline HDAC6 inhibitors. Zhao L, Fu L, Li G, Yu Y, Wang J, Liang H, Shu M, Lin Z, Wang Y	Molecular Diversity	2022
Glucose Starvation Induces a Switch in the Histone Acetylome for Activation of Gluconeogenic and Fat Metabolism Genes Hsieh WC, Sutter BM, Ruess H, Barnes SD, Malladi VS, Tu BP	Molecular Cell	2022
Coupling the immunomodulatory properties of the HDAC6 inhibitor ACY241 with Oxaliplatin promotes robust anti-tumor response in non-small cell lung cancer Bag A, Schultz A, Bhimani S, Stringfield O, Dominguez W, Mo Q, Cen L, Adeegbe D	OncoImmunology	2022
HDAC Inhibitory and Anti-Cancer Activities of Curcumin and Curcumin Derivative CU17 against Human Lung Cancer A549 Cells Namwan N, Senawong G, Phaosiri C, Kumboonma P, Somsakeesit LO, Samankul A, Leerat C, Senawong T	Molecules (Basel, Switzerland)	2022
Glioblastoma: Current Status, Emerging Targets, and Recent Advances Thakur A, Faujdar C, Sharma R, Sharma S, Malik B, Nepali K, Liou JP	Journal of Medicinal Chemistry	2022
Effect of AR42 in Primary Vestibular Schwannoma Cells and a Xenograft Model of Vestibular Schwannoma Misztal C, Bracho O, Bas E, Estivill M, Ivan ME, Morcos J, Bhatia R, Telischi F, Liu XZ, Gultekin SH, Fernandez-Valle C, Dinh CT	Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology	2022
The histone deacetylase SIRT6 promotes glycolysis through the HIF-1α/HK2 signaling axis and induces erlotinib resistance in non-small cell lung cancer. You Q, Wang J, Yu Y, Li F, Meng L, Chen M, Yang Q, Xu Z, Sun J, Zhuo W, Chen Z	Apoptosis : an international journal on programmed cell death	2022
Differential molecular mechanistic behavior of HDACs in cancer progression. Singh T, Kaur P, Singh P, Singh S, Munshi A	Medical Oncology	2022
Panobinostat enhances NK cell cytotoxicity in soft tissue sarcoma Lu X, Liu M, Yang J, Que Y, Zhang X	Clinical & Experimental Immunology	2022
Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer. Pramanik SD, Kumar Halder A, Mukherjee U, Kumar D, Dey YN, R M	Frontiers in Chemistry	2022
Targeting Heat-Shock Protein 90 in Cancer: An Update on Combination Therapy Ren X, Li T, Zhang W, Yang X	Cells	2022
Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs Sabit H, Abdel-Hakeem M, Shoala T, Abdel-Ghany S, Abdel-Latif MM, Almulhim J, Mansy M	Pharmaceutics	2022
Tackling Microbial Resistance with Isatin-Decorated Thiazole Derivatives: Design, Synthesis, and in vitro Evaluation of Antimicrobial and Antibiofilm Activity Kassab RM, Al-Hussain SA, Elleboudy NS, Albohy A, Zaki ME, Abouzid KA, Muhammad ZA	Drug design, development and therapy	2022
Heme oxygenase 1 overexpression induces immune evasion of acute myeloid leukemia against natural killer cells by inhibiting CD48 Zhang T, Fang Q, Liu P, Wang P, Feng C, Wang J	Journal of Translational Medicine	2022
Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy. Kawakubo K, Castillo CF, Liss AS	Journal of Gastroenterology	2022
Histone Deacetylase Inhibitor I3 Induces the Differentiation of Acute Myeloid Leukemia Cells with t (8; 21) or MLL Gene Translocation and Leukemic Stem-Like Cells Zhao M, Duan Y, Wang J, Liu Y, Zhao Y, Wang H, Zhang L, Chen ZS, Hu Z, Wei L	Journal of Oncology	2022
Primary cilium in kidney development, function and disease. Bai Y, Wei C, Li P, Sun X, Cai G, Chen X, Hong Q	Frontiers in Endocrinology	2022
Evidence that HDAC7 Acts as an Epigenetic “Reader” of AR Acetylation through NCoR-HDAC3 Dissociation Zhang Y, Andrade R, Hanna AA, Pflum MK	Cell Chemical Biology	2022
Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression Wang J, Li J, Zhang X, Zhang M, Hu X, Yin H	Frontiers in Molecular Biosciences	2022
MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment Bartolucci D, Montemurro L, Raieli S, Lampis S, Pession A, Hrelia P, Tonelli R	Cancers	2022
Valeric acid acts as a novel HDAC3 inhibitor against prostate cancer Han R, Yang H, Li Y, Ling C, Lu L	Medical Oncology	2022
Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways Zhu Z, McGray AJ, Jiang W, Lu B, Kalinski P, Guo ZS	Molecular Cancer	2022
Small molecule inhibitors targeting the cancers Liu G, Chen T, Zhang X, Ma X, Shi H		2022
CREPT Disarms the Inhibitory Activity of HDAC1 on Oncogene Expression to Promote Tumorigenesis Cao Y, Ning B, Tian Y, Lan T, Chu Y, Ren F, Wang Y, Meng Q, Li J, Jia B, Chang Z	Cancers	2022
TMP195 Exerts Antitumor Effects on Colorectal Cancer by Promoting M1 Macrophages Polarization Han Y, Sun J, Yang Y, Liu Y, Lou J, Pan H, Yao J, Han W	International journal of biological sciences	2022
Preclinical Development of the Class-I-Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors. Diamond JR, Pitts TM, Ungermannova D, Nasveschuk CG, Zhang G, Phillips AJ, Bagby SM, Pafford J, Yacob BW, Newton TP, Tentler JJ, Gittleman B, Hartman SJ, DeMattei JA, Winkler JD, Wendt MK, Schiemann WP, Eckhardt SG, Liu X, Piscopio AD	Molecular cancer therapeutics	2022
新型Ⅰ类和Ⅱb类选择性HDAC抑制剂甲磺酸普依司他治疗弥漫大B细胞淋巴瘤的体外药效学和作用机制研究		2022
Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies Markouli M, Strepkos D, Piperi C	International journal of molecular sciences	2022
Modified Suberoylanilide Hydroxamic Acid Reduced Drug-Associated Immune Cell Death and Organ Damage under Lipopolysaccharide Inflammatory Challenge Truong N, Goodis CC, Cottingham AL, Shaw JR, Fletcher S, Pearson RM		2022
DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors in vitro Kwesi-Maliepaard EM, Malik M, van Welsem T, van Doorn R, Vermeer MH, Vlaming H, Jacobs H, van Leeuwen F	Frontiers in Genetics	2022
Protein acylation: mechanisms, biological functions and therapeutic targets. Shang S, Liu J, Hua F	Signal Transduction and Targeted Therapy	2022
Genotype-Tailored ERK/MAPK Pathway and HDAC Inhibition Rewires the Apoptotic Rheostat to Trigger Colorectal Cancer Cell Death Jenkins LJ, Luk IY, Fairlie WD, Lee EF, Palmieri M, Schoffer KL, Tan T, Ng I, Vukelic N, Tran S, Tse JW, Nightingale R, Alam Z, Chionh F, Iatropoulos G, Ernst M, Afshar-Sterle S, Desai J, Gibbs P, Sieber OM, Dhillon AS, Tebbutt NC, Mariadason JM	Molecular cancer therapeutics	2022
Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine Lee YT, Tan YJ, Oon CE	Acta pharmaceutica Sinica. B	2022
Harnessing anti‐tumor and tumor‐tropism functions of macrophages via nanotechnology for tumor immunotherapy Zheng Y, Han Y, Sun Q, Li Z		2022
Targeting epigenetic alterations in cancer stem cells F. V, V. D. P, C. M, M. LI, C. D, G. P, D. C, A. T, M. G, S. DF, M. T, V. V, G. S		2022
Understanding Myocardial Metabolism in the Context of Cardio-Oncology Liu J, Chen ZZ, Patel J, Asnani A	Heart failure clinics	2022

Advertisement